EOLIS SANTE : revenue, balance sheet and financial ratios

EOLIS SANTE is a French company founded 19 years ago, specialized in the sector Autres activités de soutien aux entreprises n.c.a.. Based in COURBEVOIE (92400), this company of category ETI shows in 2020 a revenue of 5.5 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - EOLIS SANTE (SIREN 493685762)
Indicator 2023 2021 2020 2019 2018 2017 2016
Revenue N/C N/C 5 499 189 € 5 284 552 € 4 949 362 € 4 942 098 € N/C
Net income 1 182 214 € 1 447 517 € 1 672 538 € 1 407 978 € 1 223 880 € 1 249 849 € 1 054 720 €
EBITDA N/C N/C 2 876 290 € 2 658 930 € 2 396 095 € 2 442 423 € -2 282 534 €
Net margin N/C N/C 30.4% 26.6% 24.7% 25.3% N/C

Revenue and income statement

In 2023, EOLIS SANTE generates positive net income of 1.2 M€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2023: 1.1 M€ -> 1.2 M€.

Net income (2023) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

1 182 214 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 65%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

0.028%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

64.636%

Asset age ratio (2023) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

15.9%

Solvency indicators evolution
EOLIS SANTE

Sector positioning

Debt ratio
0.03 2023
2020
2021
2023
Q1: 0.0
Med: 5.99
Q3: 56.99
Good

In 2023, the debt ratio of EOLIS SANTE (0.03) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
64.64% 2023
2020
2021
2023
Q1: 5.84%
Med: 31.54%
Q3: 66.25%
Good

In 2023, the financial autonomy of EOLIS SANTE (64.6%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
0.0 years 2020
2020
Q1: 0.0 years
Med: 0.0 years
Q3: 1.12 years
Excellent

In 2020, the repayment capacity of EOLIS SANTE (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 142.52. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

142.524

Liquidity indicators evolution
EOLIS SANTE

Sector positioning

Liquidity ratio
142.52 2023
2020
2021
2023
Q1: 119.92
Med: 220.79
Q3: 547.18
Average -12 pts over 3 years

In 2023, the liquidity ratio of EOLIS SANTE (142.52) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
0.24x 2020
2020
Q1: 0.0x
Med: 0.0x
Q3: 0.35x
Good

In 2020, the interest coverage of EOLIS SANTE (0.2x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2023) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2023) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2023) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2023) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
EOLIS SANTE

Positioning of EOLIS SANTE in its sector

Comparison with sector Autres activités de soutien aux entreprises n.c.a.

Valuation estimate

Based on 131 transactions of similar company sales (all years), the value of EOLIS SANTE is estimated at 3 919 287 € (range 1 172 494€ - 11 539 424€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2023
131 transactions
1172k€ 3919k€ 11539k€
3 919 287 € Range: 1 172 494€ - 11 539 424€
NAF 5 all-time

Valuation method used

Net Income Multiple
1 182 214 € × 3.3x = 3 919 288 €
Range: 1 172 494€ - 11 539 424€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 131 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Autres activités de soutien aux entreprises n.c.a.)

Compare EOLIS SANTE with other companies in the same sector:

Frequently asked questions about EOLIS SANTE

What is the revenue of EOLIS SANTE ?

The revenue of EOLIS SANTE in 2020 is 5.5 M€.

Is EOLIS SANTE profitable?

Yes, EOLIS SANTE generated a net profit of 1.2 M€ in 2023.

Where is the headquarters of EOLIS SANTE ?

The headquarters of EOLIS SANTE is located in COURBEVOIE (92400), in the department Hauts-de-Seine.

Where to find the tax return of EOLIS SANTE ?

The tax return of EOLIS SANTE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does EOLIS SANTE operate?

EOLIS SANTE operates in the sector Autres activités de soutien aux entreprises n.c.a. (NAF code 82.99Z). See the 'Sector positioning' section above to compare the company with its competitors.